Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Melanoma Neoplasms × Dacarbazine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 5 Hodgkin Disease 2 Small Cell Lung Carcinoma 1 Sarcoma 1 Parathyroid Neoplasms 1 Oligodendroglioma 1 Neoplasms 1 Melanoma Neoplasms 1 Lymphoma 1 Lung Neoplasms 1 Leiomyosarcoma 1 Kidney Neoplasms 1 Hematologic Diseases 1 Gliosarcoma 1 Glioma, Subependymal 1 Glioma 1 Glioblastoma 1 Ependymoma 1 Colonic Neoplasms 1 Carcinoid Tumor 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

olaparib 1 Dacarbazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00516802 2009-05-15

A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine

AstraZeneca

Phase 1 Completed

Melanoma Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡